CERS stock forecast
Our latest prediction for Cerus Corp.'s stock price was made on the June 4, 2019 when the stock price was at 4.70$.
In the short term (2weeks), CERS's stock price should outperform the market by 4.00%. During that period the price should oscillate between -6.70% and +11.73%.
In the medium term (3months), CERS's stock price should outperform the market by 6.67%. During that period the price should oscillate between -14.80% and +28.01%.Get email alerts
About Cerus Corp.
Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
At the moment the company generates 84M USD in revenues.
On its last earning announcement, the company reported a loss of -0.49$ per share.
The book value per share is 0.68$
Three months stock forecastJune 4, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|